Clinical Trials List
2022-06-16 - 2026-06-30
Phase I/II
Recruiting7
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chueh-Chuan Yen 醫學研究部
- Chien-An Liu Division of Radiology
- Yee Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Chung-Pin Li 教學部
- Rheun-Chuan Lee Division of Radiology
- Tien-Hua Chen Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 黃宣恩 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TA-CHEN HUANG Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mengting Peng Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
- Ming-Mo Hou Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Yu-Chuan Chang Division of Nuclear Medicine
- Chi-Ju Yeh Division of Others -
- Hsien-Kun Chang Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 陳煥武 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林逢嘉 Division of Radiation Therapy
- 劉奕廷 Division of General Internal Medicine
- Yi-Ting Yen Division of Thoracic Surgery
- Yau-Lin Tseng Division of Thoracic Surgery
- Chia-Jui Yen Division of Hematology & Oncology
- Wei-Lun Chang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tai-Jan Chiu Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 林偉哲 Division of Radiology
- 陳彥豪 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 黃詩喻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ching Chen Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李 權 Division of Radiation Therapy
- 李明璟 Division of Thoracic Surgery
- 李權 Division of Radiation Therapy
- 莊政諺 Division of Thoracic Surgery
- 陳建志 Division of Radiation Therapy
- 林志鴻 Division of Thoracic Surgery
- 鄭皓升 Division of Radiation Therapy
- 趙勇全 Division of Radiation Therapy
- ZHENG-WEI ZHOU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約27 - 54 participants
-
Global
約120 participants
